Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Nicolai A Schultz; Ib J Christensen; Jens Werner; Nathalia Giese; Benny V Jensen; Ole Larsen; Jon K Bjerregaard; Per Pfeiffer; Dan Calatayud; Svend E Nielsen; Mette K Yilmaz; Niels H Holländer; Morten Wøjdemann; Stig E Bojesen; Kaspar R Nielsen; Julia S Johansen

doi:10.1371/journal.pone.0067059

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Nicolai A Schultz, Ib J Christensen, Jens Werner, Nathalia Giese, Benny V Jensen, Ole Larsen, Jon K Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E Nielsen, Mette K Yilmaz, Niels H Holländer, Morten Wøjdemann, Stig E Bojesen, Kaspar R Nielsen, Julia S Johansen

Research output: Contribution to journal › Journal article › Research › peer-review

30 Citations (Scopus)

Abstract

We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

Original language	English
Journal	P L o S One
Volume	8
Issue number	6
Pages (from-to)	e67059
ISSN	1932-6203
DOIs	https://doi.org/10.1371/journal.pone.0067059
Publication status	Published - 2013

Access to Document

10.1371/journal.pone.0067059

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Schultz, N. A., Christensen, I. J., Werner, J., Giese, N., Jensen, B. V., Larsen, O., Bjerregaard, J. K., Pfeiffer, P., Calatayud, D., Nielsen, S. E., Yilmaz, M. K., Holländer, N. H., Wøjdemann, M., Bojesen, S. E., Nielsen, K. R., & Johansen, J. S. (2013). Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. P L o S One, 8(6), e67059. https://doi.org/10.1371/journal.pone.0067059

@article{bf6ba6693037461898bb20220641fda7,

title = "Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer",

abstract = "We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.",

author = "Schultz, {Nicolai A} and Christensen, {Ib J} and Jens Werner and Nathalia Giese and Jensen, {Benny V} and Ole Larsen and Bjerregaard, {Jon K} and Per Pfeiffer and Dan Calatayud and Nielsen, {Svend E} and Yilmaz, {Mette K} and Holl{\"a}nder, {Niels H} and Morten W{\o}jdemann and Bojesen, {Stig E} and Nielsen, {Kaspar R} and Johansen, {Julia S}",

year = "2013",

doi = "10.1371/journal.pone.0067059",

language = "English",

volume = "8",

pages = "e67059",

journal = "P L o S One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "6",

}

Schultz, NA, Christensen, IJ, Werner, J, Giese, N, Jensen, BV, Larsen, O, Bjerregaard, JK, Pfeiffer, P, Calatayud, D, Nielsen, SE, Yilmaz, MK, Holländer, NH, Wøjdemann, M, Bojesen, SE, Nielsen, KR & Johansen, JS 2013, 'Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer', P L o S One, vol. 8, no. 6, pp. e67059. https://doi.org/10.1371/journal.pone.0067059

TY - JOUR

T1 - Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

AU - Schultz, Nicolai A

AU - Christensen, Ib J

AU - Werner, Jens

AU - Giese, Nathalia

AU - Jensen, Benny V

AU - Larsen, Ole

AU - Bjerregaard, Jon K

AU - Pfeiffer, Per

AU - Calatayud, Dan

AU - Nielsen, Svend E

AU - Yilmaz, Mette K

AU - Holländer, Niels H

AU - Wøjdemann, Morten

AU - Bojesen, Stig E

AU - Nielsen, Kaspar R

AU - Johansen, Julia S

PY - 2013

Y1 - 2013

N2 - We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

AB - We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

U2 - 10.1371/journal.pone.0067059

DO - 10.1371/journal.pone.0067059

M3 - Journal article

C2 - 23840582

SN - 1932-6203

VL - 8

SP - e67059

JO - P L o S One

JF - P L o S One

IS - 6

ER -

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Abstract

Access to Document

AUB Link

Fingerprint

Cite this